Indication Deviation in Women’s Health: Off-Label Drug Use from Conception to Menopause-RECORDED WEBINAR

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-23-040-H01-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Pharmacist Post-test

Learning Objectives
After completing this continuing education activity, pharmacists will be able to
• RECOGNIZE diverse instances of off-label drug use in women's health, spanning pre-conception to menopause
• DISCUSS risks and advantages associated with off-label drug utilization during various reproductive stages
• IDENTIFY the pharmacist's role in advocating for safe and informed off-label drug use for women’s health

1. Which of the following can be treated through off-label use of metformin?
A. Hirsutism of PCOS
B. PCOS with BMI ≥ 25 kg/m2
C. Endometriosis

2. Which of the following medications is used off-label to induce ovulation in women experiencing infertility and trying to conceive?
A. Letrozole
B. Clomiphene citrate
C. Cetrorelix

3. Which of the following drugs is used off-label to treat menopausal hot flashes?
A. Clonidine
B. Paroxetine
C. Fezolinetant

4. Which of the following is TRUE about off-label medication use during pregnancy?
A. All drugs have sufficient efficacy and safety data to support their use during pregnancy
B. Providers should use the letter-based FDA rating system to aid in shared clinical decision-making
C. About three-quarters of pregnant women use medications for off-label uses during pregnancy

5. A patient comes to your pharmacy experiencing frequent hot flashes. She states that a friend suggested she try taking black cohosh. She takes lisinopril for hypertension and metformin for prediabetes, and she is otherwise healthy. Which of the following is the BEST response?
A. Black cohosh will interact with your blood pressure medication, so you should not take it. Ask your doctor about clonidine instead.
B. Black cohosh shows some benefit, but clinical trials are inconsistent and available data is insufficient. You can try taking 20 mg daily for a few weeks to see if your symptoms improve.
C. Black cohosh shows no benefit whatsoever for VMS of menopause. Ask your doctor about letrozole instead.

6. Which of the following is TRUE about Pregnancy Exposure Registries?
A. They steal data about women’s babies and sell it on the black market
B. They are FDA-sponsored registries that collect health information
C. Pregnant women volunteer to share their experiences with off-label drug use

LAW: Off-Label Drug Use and The Pharmacists Role-RECORDED WEBINAR

Upon completion of this application based CE Activity, a pharmacist will be able to:

1. Define the term "off-label" in terms of drug promotion, prescribing, and use.
2. Distinguish between the use of unapproved drugs and unapproved uses of approved drugs.
3. List at least two reasons why off-label drug promotion could be harmful to patients.
4. Explain whether a pharmacist has an obligation to dispense (or not dispense) a drug prescribed for an off label
use.
5. Identify potential liabilities for pharmacists who recommend off-label use of a drug.

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-23-037-H03-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Post Test
2023 CE Finale – LAW: Off-Label Drug Use and the Pharmacist’s Role

1. Which of the following statements about off-label drug use is TRUE?
a. Connecticut’s Pharmacy Practice Act prohibits a pharmacist from dispensing a drug for a use other than its FDA-approved indication.
b. Drug companies have a First Amendment (“free speech”) right to promote FDA-approved drugs for unapproved indications.
c. Pharmacists who have declined to fill a prescription for an unapproved use have been found liable for interfering with the prescriber-patient relationship.

2. According to the FDA, which of the following statements about unapproved drugs and unapproved uses of approved drugs is FALSE?
a. Unapproved drugs have not been cleared as safe and effective by the FDA.
b. All drugs compounded pursuant to a prescription are unapproved drugs.
c. The importation and use of an unapproved drug is prohibited in all circumstances.

3. According to the Agency for Healthcare Research and Quality (AHRQ), off-label prescribing accounts for approximately what percentage of all prescriptions in the United States?
a. 3%
b. 20%
c. 40%

4. A patient asks the pharmacist to mix up some “Magic Mouthwash” consisting of two FDA-approved OTC medications (such as Benadryl liquid and Mylanta) to treat mouth sores. What should the pharmacist tell the patient?
a. The pharmacist needs to do some research; if research indicates this product is effective, he can make it.
b. A prescription is needed because the pharmacist is compounding two FDA-approved drugs for an unapproved use.
c. The pharmacist can make Magic Mouthwash because both medications are OTC (not prescription-only).

5. Which of the following statements about pharmacist responsibilities when dispensing FDA-approved drugs for an unapproved use is TRUE?
a. Unless it’s a prescription for a compounded drug, a pharmacist is obligated to verify the intended use of each drug that is dispensed pursuant to a prescription.
b. When a pharmacist recognizes that a prescription is for an off-label use, the pharmacist is obligated to inform the patient that the use is not approved by the FDA.
c. If a pharmacist recommends an off-label use of a drug to a prescriber, the pharmacist should be aware of evidence-based support for the use.

The ABCD of Off-Label Medications for Weight Management-RECORDED WEBINAR

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-23-038-H01-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

The ABCD of Off-Label Medications for Weight Management
Post Test
1. When working with a patient to manage ABCD, what is the first goal?

A. prevent weight regain
B. stop further weight gain
C. achieve weight reduction

2. Which of the following is the correct order of weight reduction efficacy (highest to lowest)?

A. tirzepatide > semaglutide > phentermine
B. semaglutide > SGLT2 inhibitors > phentermine
C. metformin = semaglutide > topiramate

3. What did the SELECT RCT report about patients 45 years and older with ABCD and existing cardiovascular disease who did not have diabetes?

A. The placebo-subtracted weight reduction for weekly semaglutide 2.4 mg was 15% of baseline body weight.
B. Subcutaneous semaglutide 2.4 mg once weekly reduced major adverse cardiovascular events in ABCD.
C. Subcutaneous semaglutide 2.4 mg once weekly significantly reduced weight but did not prevent cardiovascular events.

4. What is the most common adverse reaction for GLP-1 receptor agonist-based medications?

A. nausea and other gastrointestinal adverse effects
B. hypoglycemia
C. sleep disturbance

5. With which drug class can tirzepatide interact ?

A. beta blockers
B. ACE inhibitors
C. oral hormonal contraceptives

Time to Learn about New Cardiac Drugs-RECORDED WEBINAR

Upon completion of this application based CE Activity, a pharmacist will be able to:

Select the appropriate first and adjunctive therapies for LDL lowering in patients with differing risks according to guideline recommendations

Compare and contrast the mechanism of action and potential utility of the new LDL lowering drugs bempedoic acid and inclisirin versus traditional options

Describe hypertrophic cardiomyopathy and its risks

Identify the mechanism of action and potential utility of mavacamten versus agents currently recommended in guidelines

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-22-056-H01-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Mary Maple is an 80-year old with angina pectoris, what intensity of statin therapy should she receive and how much should her LDL be reduced?
a) Moderate intensity, 30%
b) High intensity, 50%
c) Low intensity, 20%

Mary Maple is an 55-year old with angina pectoris, what intensity of statin therapy should she receive and how much should her LDL be reduced?
a) Moderate intensity, 30%
b) High intensity, 50%
c) Low intensity, 20%

According to the CTT relationship, whether the intensity of statin was increased or adjunctive therapy with ezetimibe or evolocumab was used, the relationship between LDL lowering and cardiovascular event reduction had the same relationship
a) True
b) False

Does the CTT relationship apply to inclisirin and bempedoic acid or just to statins, ezetimibe, and PCSK9 inhibitors?
a) Yes
b) Unknown
c) No

Which of the following describes the mechanism of action correctly?
a) Inclisiran inhibits the formation of PCSK9 by inserting small interfering RNA into the cell
b) Bempedoic acid blocks the binding of PCSK9 to the LDL receptor
c) Both of the mechanisms are described correctly

Which of the new cholesterol reducing drugs can cause tendon rupture and increased uric acid?
a. Inclisiran
b. Bempedoic acid
c. Both agents

Which of the following agents can be given every six months once steady state concentrations are achieved?
a. Inclisiran
b. Bempedoic acid
c. Both agents

Hypertrophic cardiomyopathy can lead to what adverse events?
a. Atrial and ventricular arrhythmias
b. Stroke
c. Both of these issues

Mavacamten might be able to replace which of the following HCM treatments?
a. Beta-blockers of Non-DHP CCBs
b. ICDs or anticoagulants
c. Disopyramide or septal reduction therapies

Mavacamten should not be used if the left ventricular ejection fraction goes below what value?
a. 20%
b. 30%
c. 40%
d. 50%

Law: Tic-Toc, Turn Back the Clock: Pharmacy in the Post-Roe v. Wade Climate-RECORDED WEBINAR

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-22-057-H03-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Pharmacist Post-test

Learning Objectives
After completing this continuing education activity, pharmacists will be able to
• REVIEW the original Roe v. Wade ruling and how it impacted healthcare in the United States
• DISCUSS Dobbs v. Jackson Women’s Health Organization and its impact on Roe v. Wade
• IDENTIFY the implications of these Supreme Court rulings on pharmacy practice

1. What did the original Roe v. Wade ruling do?
A. Made abortion legal in the U.S. at any gestational age for any reason
B. Left it up to individual states in the U.S. to regulate abortion at any gestational age
C. Made abortion legal in the U.S. through the first trimester of pregnancy

2. What did the Planned Parenthood of Southeastern Pennsylvania v. Casey ruling do?
A. Overturned Roe v. Wade and made abortion illegal across the U.S.
B. Provided states the ability to pass more restrictive laws regarding abortion
C. Laid the groundwork for Dobbs v. Jackson Women’s Health Organization

3. What did the Dobbs v. Jackson Women’s Health Organization ruling do?
A. Made abortion illegal in the U.S. at any gestational age for any reason
B. Left it up to individual states in the U.S. to regulate abortion at any gestational age
C. Made abortion illegal in the U.S. after the first trimester of pregnancy

4. Which of the following was the first successful 6-week abortion ban after the Roe v. Wade ruling?
A. Gestational Age Act
B. Partial-Birth Abortion Ban
C. Heartbeat Act

5. Which of the following states would be MOST likely to enforce abortion bans through criminal penalties?
A. Tennessee
B. New Mexico
C. Florida

6. Which of the following is TRUE about EMTALA?
A. It effectively supersedes state law regarding abortion
B. It states that providers must abort ectopic pregnancies
C. It is not enforceable in the case of abortion care

7. Which of the following is TRUE about dispensing intramuscular methotrexate following the overturn of Roe v. Wade?
A. Pharmacists should use clinical judgment to practice corresponding responsibility and follow state laws
B. It is illegal to dispense to a woman of childbearing age unless they have documented psoriatic arthritis
C. Refusing to fill for any reason is illegal, and pharmacists will face fines and imprisonment for discrimination

8. Which of the following is the BEST way to prevent discrimination or perceived discrimination?
A. Ask all women of childbearing age about pregnancy status when they fill teratogenic medications
B. Decline to fill all prescriptions for abortifacient medications for women of childbearing age
C. Ask individuals about their religious beliefs before offering them employment

9. Which of the following is TRUE about federal preemption?
A. It requires physicians to use telehealth to prescribe medication abortion drugs if patients request
B. It supersedes the FDA to prohibit providers from prescribing opioids to women of childbearing age
C. The Women’s Health Protection Act of 2021 may provide federal preemption regarding abortion services

10. A woman presents to the emergency department at your hospital experiencing complications related to a miscarriage during the ninth week of pregnancy. You work in a state where a 6-week abortion ban is in effect, and a provider suspects the individual of having taken medication to end their pregnancy. A coworker insists on reporting this information to authorities because she does not want to be liable for withholding the information from law enforcement. The law does not require the hospital to report individuals to law enforcement for intentionally ending a pregnancy, but your coworker states that the HIPAA Privacy Rule allows this kind of disclosure. What should you do?
A. Assure your coworker that reporting this patient to law enforcement is an unlawful disclosure of PHI
B. Let your coworker report this information to law enforcement and then report your coworker for PHI disclosure
C. Report this patient to law enforcement so that you are not held liable if she is later charged with unlawful abortion

LAW: Legal Perspectives on New and Evolving Issues in Pharmacy-RECORDED WEBINAR

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-22-054-H03-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Post Test

Legal Perspectives on New and Evolving Issues in Pharmacy
Post-test
At the conclusion of this CPE activity, participants should be able to:
1. Describe recent industry trends and regulatory actions affecting pharmacists’ workplace conditions
2. Explain how a refusal to fill a legitimate prescription might result in civil liability
3. Identify emerging approaches to containing the cost of drugs

1. When thinking about health-system pharmacists who participated in a survey of well-being, which of the following is TRUE?
A. The majority of pharmacists indicated that their organizations offered resources to improve well-being and that they had used the resources.
B. Pharmacists who had a greater number of non-clinical duties were least likely to report negative effects on well-being.
C. Only a small percentage of these pharmacists—14.5%—were aware of resources offered by their organizations that could help improve well-being.

2. When reading stories published in various newspapers across the country, which of the following may be a limitation in their findings?
A. The people who conducted the “research” are not pharmacists.
B. The “data” is not collected in a structured, evidence-based way.
C. The newspapers rarely fact-check information before publishing.

3. A patient presents a prescription for emergency contraception on a Saturday evening. The sole pharmacist on duty refuses to fill it based on his religious beliefs and says he will also be the only pharmacist on duty on Sunday and Monday. Which of the following actions may INCREASE the likelihood of civil litigation?
A. The pharmacist tells the patient nothing other than he belongs to a religious sect that considers emergency contraception an abortifacient and he will not fill it.
B. The pharmacist tells the patient that the chain pharmacy across the street is open for another two hours, stocks the medication, and can fill the prescription.
C. The pharmacist asks the patient if she would like him to call his coworker and ask the coworker to come in within 24 hours to fill this prescription.

4. Which of the following prescriptions (which pharmacists refused to fill to treat COVID) resulted in a lawsuit against Walmart and Hy-vee pharmacies that was ultimately dismissed?
A. ivermectin and hydroxychloroquine
B. sodium hyochlorite and ivermectin
C. hydroxychloroquine and molnupiravir

5. Which of the following would reduce prescription drug costs for Medicare patients?
A. The 340B Program
B. Price disrupters and PBMs
C. Inflation Reduction Act of 2022

6. Which of the following terms and descriptions are matched correctly?
A. Clear Bagging: Having the health system’s specialty pharmacy fill the prescription and transport it directly to the place where it will be given.
B. Brown Bagging: Having a specialty pharmacy ship a medication directly to the hospital or clinic so it can be administered to the patient there.
C. Gold Bagging: Having a patient fill a prescription by whatever means available and bring it to the hospital or doctor’s office for administration.

What in the World: A Global Look at Healthcare and Drugs-RECORDED WEBINAR

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-22-055-H04-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

World Health Post Test – CE Finale

After completing this continuing education activity, pharmacists will be able to
1. Describe the key components of global healthcare systems
2. Discuss the performance indicators of global health systems
3. Compare pharmaceutical drug spending levels and trends globally
4. Define medical tourism and analyze its associated risks and benefits

Which of the following are key components in global health systems?

a. Wait times, patient satisfaction, propensity to result in personal bankruptcy, number of healthcare professionals employed, accreditation

b. Type of ownership (public vs. private), patient’s financial obligations, extent of coverage (e.g., preventive, inpatient, outpatient care, etc.)

c. Antibiotic resistance, risk of exposure to blood borne diseases, long distance travel, exposure to unusual infections

What is a common problem encountered in the universal payer model that is frequently used as a performance measure?

a. High out of pocket cost of care

b. Long wait times

c. Higher mortality rates

In comparison to other high-income countries, where does the U.S system’s administrative efficiency rank?

a. 9th

b. 10th

c. 11th

A student under your supervision is filling a prescription for a newly approved drug. She asks if it is a biologic and you say no, it is a drug (also called a small molecule) and explain the difference between a drug and a biologic, most of which are specialty medications. She says that she heard that long patent lives on innovative drugs fuel pharmaceutical drug spending. What do you tell her?

a. “You are incorrect. The largest contributor to increased spending for pharmaceuticals is specialty medications”

b. “You are incorrect. The largest contributor to increased spending for pharmaceuticals is COVID-19 therapeutics.”

c. “You are incorrect. The largest contributor to increased spending for pharmaceuticals is over the counter medications.”

First-Line Medication Therapy for Type 2 Diabetes: Time for a Change? -RECORDED WEBINAR

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-22-058-H01-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

First-Line Therapy for Type 2 Diabetes: Time for a Change?

1. What is the MOST IMPORTANT therapeutic goal in the management of diabetes?
a. Reduce the A1c to <7%
b. Prevent the development of long-term complications of diabetes
c. Save money from costly treatments

2. What is the most common cause of mortality in people with uncontrolled type 2 diabetes?
a. Complications of atherosclerotic cardiovascular disease
b. Neuropathic pain
c. Diabetic eye disease

3. Tirzepatide belongs to which of the following drug class?
a. GLP-1 receptor agonists
b. Dual GIP/GLP-1 receptor agonist
c. SGLT2 inhibitors

4. Mr. N, the hypothetical patient from the presentation, is prescribed tirzepatide by his PCP. Which of the following would be expected as a COMMON side effect of tirzepatide?
a. Pancreatitis
b. Neuropathic pain
c. Nausea

5. Which of the following statements is TRUE according to the 2023 American Diabetes Association’s diabetes guidelines?
a. Four areas are equally emphasized: glycemic management, weight management, cardiovascular risk factor management, and cardiorenal protection.
b. Glycemic control is the most important therapeutic goal and prescribers should encourage all patient to strive for a HbA1c lower than 6.
c. Prevention of kidney complications of diabetes should be emphasized above other management strategies.

6. Which of the following drug class is associated with the LOWEST potential for weight loss (hint: see the tables at the end of the presentation)?
a. Biguanide (metformin)
b. SGLT2 inhibitors
c. GLP-1 receptor agonists

Immunization: Is Winter Here? – An Update on Monkey Pox and Covid Vaccines-RECORDED WEBINAR

Upon completion of this application based CE Activity, a pharmacist will be able to:

1. Discuss trends in the epidemiology of the COVID-19 pandemic and Monkeypox outbreak.

2. Discuss current clinical data on the safety and effectiveness of (i) the bivalent COVID-19 booster vaccines and (ii) the JYNNEOS or ACAM2000 vaccines for Monkeypox.

3. Explain whether a person would be eligible for receipt of (i) the bivalent COVID-19 booster vaccines and/or (ii) the JYNNEOS or ACAM2000 vaccines for Monkeypox.

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-22-059-H06-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Good news! News reporters and Internet sites began announcing in the spring and summer of 2022 that the global pandemic had ended. What do you think of that?
1. YAY! Science prevailed and we obliterated that bad boy and sent it away!
2. FAKE NEWS. Approximately 2,000 Americans still die each week from (or with) active COVID-19 disease.
3. CORRECT, but COVID is still a major concern in our socially inclined young adults.

What does the data say about adverse effects associated with the bivalent COVID-19 boosters?
1. The most common adverse effects are systemic (fever, chills, fatigue)
2. The most common adverse effects are central (headache, mental fogginess)
3. The most common adverse effects are local (pain, erythema, swelling)

Based on current vaccination statistics about populations that have the poorest booster coverage for COVID-19, which of the following population should pharmacists be encouraging to GET VACCINATED!?!
1. Children age 5 or younger in the Great Lakes regions
2. People older than 65 in the Pacific northwest
3. Everybody everywhere
4. Monkeypox is the name and name-changing is the game. What has the World Health organization decided to call this infection and why?
5. It will be monk's disease, which will remove some of the stigmatizing language and remind people to live like a monk until the lesions disappear.
6. It will be mpox, which is intended to dissuade people from using racist and stigmatizing language to describe people infected with this virus.
7. It will be var-vac-human, reflecting its similarity to variola (smallpox) and vaccinia (viral vaccine for smallpox) and its zoonotic transmission.

What is eczema vaccinatum?
A complication of the ACAM2000 vaccination that can occur in patients who have eczema/atopic dermatitis, in which vaccinia virus disseminates to cause an extensive rash and systemic illness.
A complication of the JYNNEOS vaccination that can occur in patients who have eczema/atopic dermatitis, in which vaccinia virus disseminates to cause an extensive rash and systemic illness.
A complication of the ACAM2000 vaccination that can occur in patients who have any chronic skin condition, in which vaccinia virus disseminates to cause an extensive rash and systemic illness.

Andi is a person living with HIV infection who also is prone to keloids. This patient wants the JYNNEOS vaccination for mpox. What is the best course of action?
1. Administer the vaccine intradermally
2. Administer the vaccine subcutaneously
3. Recommend using ACAM2000 instead

Over the Counter Hearing Aids: Breaking Sound Barriers in Community Pharmacy-RECORDED WEBINAR

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this knowledge-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-22-060-H01-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Post Test

1.Which of the following symptoms is indicative of mild to moderate hearing loss

Recent treatment for an ear infection
Difficulty maintaining conversation in quiet environments
Watching TV with subtitles on

M.M., a 75-year-old female, arrives at the pharmacy to pick up her celecoxib prescription (which she takes for arthritis) and to return the ITC-style OTC hearing aids she purchased two weeks ago. When you ask why she's returning the hearing devices, she expresses that she "doesn't need them" as much as she thought, then adds "they feel ok when they're in, but I'm nervous that like they're going to just pop out of my head." Which alternative style of OTC hearing aid might better address M.M.'s needs and priorities?

Completely-in-Canal
Behind-the-Ear
Personal Sound Amplification Product

3.D.J. is a regular patient at your pharmacy; today he's joined by his niece. You know that he has difficulty hearing, especially in the busy pharmacy, and make a mental note to remove your mask and speak slowly while you're talking to him. As D.J. and his niece wait for his prescription to be filled, D.J.'s niece points out the OTC hearing aid display by the counter and suggests that "something like that would be perfect for you!" D.J. remarks that he "isn't some bionic action figure and can hear just fine." What is D.J.'s greatest barrier to accessing OTC hearing aids?

Severe hearing loss
No perceived need
Accessibility

Which medication is most likely to cause hearing loss?
Gentamycin
Hydrochlorothiazide
Ibuprofen
Methotrexate

C.S. is a 72-year-old female with moderate hearing loss. Her past medical history also includes diabetes and recent total knee replacement surgery. After her knee replacement, she moved into assisted living and “is excited to meet more of my neighbors and maybe even sign up for a pottery class.” C.S. noticed that OTC hearing aids are available at her local pharmacy and believes that they could help her be more involved in her new community. Which of the following patient-specific characteristics will influence the outcomes of OTC hearing aid use?

Limited mobility
Age
Self-efficacy

Individuals with untreated hearing loss are more likely to experience which of the following?
Social isolation
Improved cognition
Reversible hearing loss

Pharmacists are expected to play a new and important role as healthcare providers as hearing aids hit the shelves of community pharmacies. Which of the following best describes how pharmacists will participate in OTC hearing aid provision?

Diagnose underlying causes of hearing loss
Administer hearing tests to interested individuals
Employ effective communication strategies

About this Course

Learning Objectives

Additional Information

Accreditation Statement

Grant Funding

Faculty

Faculty Disclosure

Disclaimer

Content

Handouts

About this Course

Learning Objectives

Additional Information

Accreditation Statement

Grant Funding

Faculty

Faculty Disclosure

Disclaimer

Content

Post Test (for viewing only)

Handouts

About this Course

Learning Objectives

Additional Information

Accreditation Statement

Grant Funding

Faculty

Faculty Disclosure

Disclaimer

Content

Post Test

Post Test

Handouts

About this Course

Learning Objectives

Additional Information

Accreditation Statement

Grant Funding

Faculty

Faculty Disclosure

Disclaimer

Content

Handouts

About this Course

Learning Objectives

Additional Information

Accreditation Statement

Grant Funding

Faculty

Faculty Disclosure

Disclaimer

Content

Handouts

About this Course

Learning Objectives

Additional Information

Accreditation Statement

Grant Funding

Faculty

Faculty Disclosure

Disclaimer

Content

Post Test (for viewing only)

Handouts

About this Course

Learning Objectives

Additional Information

Accreditation Statement

Grant Funding

Faculty

Faculty Disclosure

Disclaimer

Content

Handouts

About this Course

Learning Objectives

Additional Information

Accreditation Statement

Grant Funding

Faculty